MEDPACE HOLDINGS, INC. (NASDAQ:MEDP) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.Submission of Matters to a Vote of Security Holders.
On May 19, 2017, Medpace Holdings, Inc. (the Company) held its
2017 Annual Meeting of Stockholders. As of March 27, 2017, the
record date for the Annual Meeting, there were 40,734,811 shares
of Common Stock outstanding and entitled to vote at the Annual
Meeting.A quorum was present at the Annual Meeting, as required
by the Companys Amended and Restated Bylaws.
Proposal 1 Election of Directors
The following three individuals were elected to the Companys
Board of Directors to serve as Class I Directors until the
Companys 2020 Annual Meeting of Stockholders, and until their
respective successors shall have been duly elected and qualified.
|
Votes For |
Votes Withheld |
Broker Non-Votes |
|
|
Bruce Brown |
38,518,764 |
177,175 |
1,287,342 |
|
Brian T. Carley |
37,232,030 |
1,463,909 |
1,287,342 |
|
Robert O. Kraft |
37,353,550 |
1,342,389 |
1,287,342 |
Proposal 2 Ratification of Appointment of Independent Registered
Public Accounting Firm
The appointment of Deloitte Touche LLP as the Companys
independent registered public accounting firm for the fiscal year
ending December 31, 2017 was ratified.
|
Votes For |
Votes Against |
Votes Abstained |
Broker Non-Votes |
|
39,844,416 |
22,251 |
116,614 |
About MEDPACE HOLDINGS, INC. (NASDAQ:MEDP)
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia. MEDPACE HOLDINGS, INC. (NASDAQ:MEDP) Recent Trading Information
MEDPACE HOLDINGS, INC. (NASDAQ:MEDP) closed its last trading session down -0.12 at 26.67 with 102,584 shares trading hands.
